Search

Clinical impact of genetic polymorphisms observed in the pharmacokinetics of the novel PPAR agonist, Sipoglitazar

Therapeutic area :

Stringer F., Jongh J.d, Ploeger B., Scott G., Urquart R. and Danhof M., Clinical impact of genetic polymorphisms observed in the pharmacokinetics of the novel PPAR agonist, Sipoglitazar. Noordwijkerhout.(2010)

Our expertise

Biologicals General modelling Paediatrics Pain Methods Endocrinology/Sexual health Anesthesiology Lung Diseases Blood disorders CNS Cardiovascular Safety pharmacology Diabetes Oncology Anti-infectives and immunology Peripheral Nervous System Gastrointestinal Diseases